Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

NCT ID: NCT05270629

Last Updated: 2022-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

87 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-06

Study Completion Date

2022-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphedema of Leg

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lower limb lymphedema patients

This was a retrospective cohort propensity score-matched study. Patients with lower limb lymphedema were enrolled.

Antegrade and retrograde anastomoses

Intervention Type OTHER

Patients who had received both antegrade and retrograde anastomoses.

Antegrade-only anastomoses

Intervention Type OTHER

Patients who had received antegrade-only anastomoses.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Antegrade and retrograde anastomoses

Patients who had received both antegrade and retrograde anastomoses.

Intervention Type OTHER

Antegrade-only anastomoses

Patients who had received antegrade-only anastomoses.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lower limb lymphedema patients.

Exclusion Criteria

* Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chang Gung Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ching-Hua Hsieh, PhD

Role: CONTACT

+886-7-7317123 ext. 2947

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hsiao-Yun Hsieh, MSc

Role: primary

+886-7-7317123 ext. 2947

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202101384B0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Swedish External Support Study
NCT01273740 COMPLETED NA